PRA Health Sciences任命FDA高级官员领导新的去中心化临床试验战略全球卓越中心
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ：PRAH）今天宣布任命Isaac...
PRA Health Sciences nombra alto funcionario de la FDA para liderar el nuevo Centro Global de Excelencia para la Estrategia de Ensayos Clínicos Descentralizados
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
RALEIGH, CAROLINA DEL NORTE, Nov. 23, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) anunció hoy el nombramiento del Dr. Isaac Rodríguez-Chávez, PhD, MHS, MS, como vicepresidente...
PRA Health Sciences 任命高級 FDA 官員領導新全球分散式臨床試驗策略卓越中心
November 23, 2020 14:28 ET
|
PRA Health Sciences, Inc.
北卡羅萊納州拉里格, Nov. 24, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈任命 Isaac Rodriguez-Chavez 博士、環境健康科學碩士兼理學碩士為科學和臨床事務高級副總裁。他將領導公司的全球分散式臨床試驗策略卓越中心。Rodriguez-Chavez 博士的職責包括實現...
PRA Health Sciences appoints senior FDA official to lead new Global Center of Excellence for Decentralized Clinical Trial Strategy
November 19, 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C. , Nov. 19, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) announced today the appointment of Isaac Rodriguez-Chavez, PhD, MHS, MS, as Senior Vice President,...
PRA Health Sciences, Inc. Reports Third Quarter 2020 Results and Updates Full Year 2020 Guidance
November 04, 2020 16:01 ET
|
PRA Health Sciences, Inc.
Net new business of $737.9 million; representing growth of 10.2%; Net book-to-bill of 1.28 excluding reimbursement revenueNet new business of $986.0 million; Net book-to-bill of 1.35 including...
PRA Health Sciences to Report Third Quarter 2020 Earnings
October 07, 2020 17:09 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its third quarter 2020 results after the market closes on Wednesday, November 4, 2020. The...
PRA Health Sciences selecionada pela BARDA como membro da sua exclusiva Rede de Estudos Clínicos
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Oct. 07, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences , Inc.(NASDAQ: PRAH) anunciou hoje que foi selecionada pela Biomedical Advanced Research and Development Authority (BARDA) como...
PRA 헬스사이언스, BARDA로부터 임상 연구 네트워크 회원사로 선정
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, Oct. 08, 2020 (GLOBE NEWSWIRE) -- PRA 헬스사이언스(PRA Health Sciences, Inc. (NASDAQ:PRAH))는 미국 생물의약품첨단연구개발국(BARDA)으로부터 업데이트된 임상연구 네트워크(Clinical Studies Network) 회원사로 등록되었다고 밝혔다. 임상시험 계획 및...
BARDA 選擇 PRA Health Sciences 作為為其專屬臨床研究網絡的成員
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
新澤西州拉里市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) 今天宣佈公司已獲生物醫學高級研究和開發管理局 (BARDA) 選為最新臨床研究網絡 (CSN) 的成員。PRA 獲授予臨床試驗計劃和執行 (CTPE)...
PRA Health Sciences被BARDA选为其独家临床研究网络的成员
October 07, 2020 11:10 ET
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, Oct. 07, 2020 (GLOBE NEWSWIRE) -- Health Sciences, Inc.（NASDAQ：PRAH）今天宣布已被生物医学高级研究与发展管理局（BARDA）选为最新临床研究网络（CSN）的成员。按照临床试验规划和实施（CTPE）合同的规定，...